LADENBURG THALMANN FINANCIAL SERVICES INC. - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$51,000
-21.5%
8,5380.0%0.00%
Q3 2019$65,000
-54.5%
8,538
-18.2%
0.00%
-100.0%
Q2 2019$143,000
+130.6%
10,433
-8.3%
0.00%
Q1 2019$62,000
+181.8%
11,383
+58.9%
0.00%
Q4 2018$22,000
-65.6%
7,163
-8.0%
0.00%
-100.0%
Q3 2018$64,000
-15.8%
7,788
-11.1%
0.00%0.0%
Q2 2018$76,0000.0%8,7650.0%0.00%0.0%
Q1 2018$76,000
-30.9%
8,765
-0.7%
0.00%0.0%
Q4 2017$110,000
+48.6%
8,8240.0%0.00%0.0%
Q3 2017$74,000
+289.5%
8,824
+669.3%
0.00%
Q2 2017$19,000
-24.0%
1,147
-8.8%
0.00%
Q1 2017$25,000
+1150.0%
1,258
+1158.0%
0.00%
Q4 2016$2,000
+100.0%
1000.0%0.00%
Q3 2016$1,0000.0%1000.0%0.00%
Q2 2016$1,0000.0%1000.0%0.00%
Q1 2016$1,0000.0%1000.0%0.00%
Q4 2015$1,0000.0%1000.0%0.00%
Q3 2015$1,0001000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 2,679,457$20,257,0000.73%
Portolan Capital Management 777,293$5,876,0000.66%
CAMPBELL CAPITAL MANAGEMENT INC 110,451$835,0000.62%
ZEKE CAPITAL ADVISORS, LLC 402,212$3,041,0000.27%
Leap Investments LP 46,084$348,0000.17%
Bernardo Wealth Planning LLC 26,419$199,0000.14%
Claraphi Advisory Network, LLC 14,744$111,0000.07%
Sterling Investment Advisors, Ltd. 11,000$83,0000.04%
A.R.T. Advisors, LLC 81,372$615,0000.03%
Mirae Asset Global Investments Co., Ltd. 544,408$4,116,0000.03%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders